- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03337178
Fitbit Pilot Study in Post-operative Lumbar Degenerative Spinal Stenosis Patients
August 20, 2020 updated by: The London Spine Centre
Fitbit Pilot Study to Increase Physical Activity and Overall Health in Post-operative Lumbar Degenerative Spinal Stenosis Patients
Spinal stenosis is a common orthopedic spine condition that limits individuals ability to walk and stand because of nerve compression.
Surgical treatment can alleviate leg pain and improve function such as increasing physical activity.
This study will use Fitbit technology to monitor patient's post-operative physical activity.
It will evaluate the efficacy of a Fitbit incentive based walking program on improving post-operative physical activity and rehabilitation.
Study Overview
Status
Unknown
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Anticipated)
60
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Ontario
-
London, Ontario, Canada, N6G 5L7
- Recruiting
- London Health Sciences Centre
-
Contact:
- Christopher S Bailey, MD
- Phone Number: 55358 519-685-8500
- Email: Chris.Bailey@lhsc.on.ca
-
Principal Investigator:
- Christopher S Bailey, MD
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
60 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- 60 years of age and older
- diagnosed with neurogenic claudication or radiculopathy secondary to central or lateral recess stenosis between L3-L5 confirmed by CT or MRI
- consent for surgical treatment
Exclusion Criteria:
- traumatic stenosis from a pathologic fracture
- inflammatory spine disease
- peripheral arterial disease
- hip or knee arthritis or pulmonary or circulatory diseases for which exercise is contraindicated
- severe or progressive neurologic deficit effecting ambulatory ability
- cancer
- no access to a computer or mobile device
- inability to complete the questionnaires or provide follow-up (i.e. lack of permanent address, substance abuse, interfering psychiatric illness).
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
No Intervention: Control
Standard of care
|
|
Experimental: Blinded Fitbit
Blinded Fitbit, no step goal, and no activity feedback
|
Fitbit is worn for 3 months post-operatively with no activity feedback or step goals
|
Experimental: Fitbit
Fitbit plus step goal and activity feedback
|
Fitbit is worn for 3 months post-operatively with feedback and step goals
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Self-Paced Walking Test
Time Frame: Change in 3 months post-op from baseline
|
Variability of the self-paced walking test
|
Change in 3 months post-op from baseline
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Patient Recruitment
Time Frame: Number consented by 17 months
|
Participants will be included if they are 60 years of age and older, diagnosed with neurogenic claudication or radiculopathy secondary to central or lateral recess stenosis between L3-L5 confirmed by CT or MRI, and consent for surgical treatment.
Include patients with Grade 1 spondylolithesis.
Patients will be excluded if the stenosis was not degenerative (i.e.
traumatic stenosis from a pathologic fracture), they had inflammatory spine disease, they had peripheral arterial disease, or pulmonary or circulatory diseases for which exercise is contraindicated, osteoarthritis in the lower extremities, severe or progressive neurologic deficit requiring urgent surgery, cancer, previous lumbar surgery, they have no access to a computer or mobile device, an inability to complete the questionnaires or provide follow-up (i.e.
lack of permanent address, substance abuse, interfering psychiatric illness).
|
Number consented by 17 months
|
Self-paced walking test
Time Frame: Change in 3 months post-op from baseline
|
Self-paced walk test (SPWT) is a validated measure of walking capacity in lumbar degenerative spinal stenosis.
The individual walks comfortably at his/her own pace until he/she must rest due to symptoms of back or leg pain.
The total time and distance walked is recorded, time/distance to onset of symptoms, and nature and location of symptoms (pain numbness/tingling, weakness or fatigue), average walking speed, and reason for termination (symptoms of LSS, fatigue, shortness of breath, pain, other comorbidities).
Patients are not permitted to use an assistive device.
The test is either self-terminated (complete stop of 3 seconds or more) due to symptoms or at 30 minutes whichever occurs first.
Participants are asked to indicate when they first experience symptoms.
|
Change in 3 months post-op from baseline
|
Steps walked/day
Time Frame: Change in 3 months post-op from baseline
|
Comparison of Fitbit activity data of steps taken between groups
|
Change in 3 months post-op from baseline
|
Leg Pain
Time Frame: Change in 3 months post-op from baseline
|
Numeric Rating Score for Leg Pain.
The (NRS) for leg pain numeric rating scale ranges from 0 to 10, with lower scores indicating less severe symptoms
|
Change in 3 months post-op from baseline
|
Back Pain
Time Frame: Change in 3 months post-op from baseline
|
Numeric Rating Score for Back Pain.
The (NRS) for back pain numeric rating scale ranges from 0 to 10, with lower scores indicating less severe symptoms
|
Change in 3 months post-op from baseline
|
General Health
Time Frame: Change in 3 months post-op from baseline
|
General health assessed by SF12.
The SF12 is a generic, multidimensional self-report health questionnaire and is validated when applied to the spine patient.
Questions are categorized into scales for general health, physical functioning, social functioning, role limitation-physical, role limitation-emotional, mental health, energy/fatigue, pain, comparative health.
These are summarized into the SF12-physical component summary score (PCS) and mental component summary score (MCS).
Scores range from 0 to 100.
Higher scores imply better functioning.
|
Change in 3 months post-op from baseline
|
Functional Ability
Time Frame: Change in 3 months post-op from baseline
|
Functional ability assessed by Oswestry Disability Index.
Oswestry Disability Index (ODI) is a validated questionnaire in lumbar degenerative spinal stenosis patients that assesses back pain-related disability.
A higher score denotes worsening disability.
|
Change in 3 months post-op from baseline
|
Functional Ability
Time Frame: Change in 3 months post-op from baseline
|
Functional ability assessed by Swiss Spinal Stenosis Questionnaire.
Swiss spinal stenosis questionnaire (SSS) is a validated 12-item condition-specific instrument for lumbar degenerative spinal stenosis that is known to be internally consistent and reliable and responsive to clinical change.
It is a self-reported measure of pain and physical function.
Higher scores represent worse physical function.
The score for physical function was calculated as the un-weighted mean of the five items of the scale.
The resulting possible scores of 1-4 represent mild to severe limitation in physical function.
The Symptom Severity Scale will be used by averaging the scores the seven items.
Responses range from 1-7 indicating mild to severe pain.
|
Change in 3 months post-op from baseline
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
August 1, 2018
Primary Completion (Anticipated)
August 31, 2022
Study Completion (Anticipated)
December 31, 2022
Study Registration Dates
First Submitted
July 11, 2017
First Submitted That Met QC Criteria
November 6, 2017
First Posted (Actual)
November 8, 2017
Study Record Updates
Last Update Posted (Actual)
August 21, 2020
Last Update Submitted That Met QC Criteria
August 20, 2020
Last Verified
August 1, 2020
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- ReDA359
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Lumbar Degenerative Spinal Stenosis
-
Azienda Usl di BolognaRecruitingLumbar Spinal Stenosis | Degenerative Lumbar Spinal StenosisItaly
-
Peking University Third HospitalRecruitingDegenerative Scoliosis | Degenerative Lumbar Spinal StenosisChina
-
Ohio State UniversityNexxt Spine, LLCCompletedLumbar Spinal Stenosis | Lumbar Spondylolisthesis | Lumbar Degenerative Disc Disease | Lumbar Spondylosis | Lumbar Spinal DeformityUnited States
-
Seoul National University HospitalCompletedDegenerative Lumbar Spinal StenosisKorea, Republic of
-
BioAlpha Inc.CompletedDegenerative Lumbar Spinal Stenosis
-
Taipei Veterans General Hospital, TaiwanCompletedDegenerative Lumbar Spinal Stenosis | Lumbarsacral Orthosis | Transforaminal Lumbar Interbody FusionTaiwan
-
National Taiwan University HospitalRecruitingDegenerative Disc Disease | Degenerative Spondylolisthesis | Degenerative Intervertebral Discs | Degenerative Lumbar Spinal StenosisTaiwan
-
Seoul National University HospitalCompletedDegenerative Lumbar Spinal StenosisKorea, Republic of
-
Haukeland University HospitalMøre og Romsdal Hospital TrustActive, not recruitingDegenerative Spondylolisthesis | Degenerative Lumbar Spinal StenosisNorway
-
Spine Centre of Southern DenmarkCompletedDegenerative Spondylolisthesis | Degenerative Lumbar Spinal StenosisDenmark
Clinical Trials on Blinded Fitbit
-
Mayo ClinicCompleted
-
Lexicon PharmaceuticalsRecruitingDiabetic Peripheral Neuropathic PainUnited States
-
Ohio State UniversityNational Institute of Nursing Research (NINR); National Institutes of Health...CompletedCardiovascular Diseases | Physical Activity | Kidney Transplant; Complications | Cardiorenal; ChangeUnited States
-
University of South CarolinaCompletedArthroplasty, Replacement, KneeUnited States
-
Woman'sDexCom, Inc.RecruitingPostpartum Gestational Diabetes MellitusUnited States
-
Seattle Children's HospitalCompleted
-
University of IowaNational Heart, Lung, and Blood Institute (NHLBI)CompletedSedentary Lifestyle
-
AstraZenecaRecruitingSystemic Sclerosis | SclerodermaUnited Kingdom, United States, Italy, Mexico, Belgium, Germany, Spain, China, France, India, Austria, Canada, Poland, Israel, Korea, Republic of, Hungary, Japan, South Africa, Turkey, Netherlands, Romania
-
Dana-Farber Cancer InstituteCompleted